EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ELUSINE CORACANA LEAF EXTRACT MITIGATES DYSLIPIDEMIA AND MODULATES INFLAMMATION BIOMARKERS IN TESTOSTERONE PROPIONATE - INDUCED BENIGN PROSTATIC HYPERPLASIA IN RATS

Chioma Adaeze Duru, Obinna Ajah, Ikenna Elvis Nnaoma, Rich C Joseph

Universal Journal of Pharmaceutical Research · 15.05.2026

DOI: 10.22270/ujpr.v11i2.1535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Universal Journal of Pharmaceutical Research, online erschienen am 15.05.2026. Verfasst von Chioma Adaeze Duru und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Benign Prostatic Hyperplasia (BPH) is an age-related condition characterized by prostate enlargement, lower urinary tract symptoms (LUTS), and persistent inflammation. Although conventional treatments such as α1-adrenergic blockers and 5α-reductase inhibitors (e.g., finasteride) can relieve symptoms, their use is frequently associated with undesirable side effects. This study evaluated the effect of ethanol extract of Eleusine coracana leaves on serum lipid profile and inflammatory cytokines in a testosterone propionate (TP)-induced BPH rat model.

Methods

Thirty male Wistar rats were randomly assigned to six groups: normal control, TP-induced BPH control, finasteride-treated group, and three groups treated with E. coracana extract at doses of 100, 200, and 400 mg/kg. Serum lipid parameters (triglycerides, total cholesterol, HDL, and LDL) and inflammatory cytokines (IL-6 and TNF-α) were assessed, together with prostatic levels of IL-6 and TNF-α.

Results

The results revealed that TP-induced BPH caused significant dyslipidemia (increased TG, TC, LDL, and decreased HDL) and elevated systemic and prostatic cytokines compared to controls. Treatment with E. coracana extract significantly improved lipid profiles and reduced pro-inflammatory cytokine levels in a dose-dependent manner, with effects comparable to finasteride. Notably, the 400 mg/kg extract normalized HDL and prostatic IL-6 levels, indicating strong anti-inflammatory and lipid-modulating activity.

Conclusion

These findings suggest that E. coracana leaf extract may serve as a promising adjunct or alternative therapy for BPH, particularly in patients with concurrent metabolic risk factors. Peer Review History: Received 6 February 2026; Reviewed 12 March 2026; Accepted 15 April; Available online 15 May 2026 Academic Editor: Dr. Jennifer Audu-Peter, University of Jos, Nigeria, drambia44@gmail.com Reviewers: Dr. Alfonso Alexander Aguileral, University of Veracruz, Mexico, aalexander_2000@yahoo.com Dr. Sangeetha Arullappan, Universiti Tunku Abdul Rahman, Malaysia, sangeetha@utar.edu.my

Zitieren

APA

Duru, C. A., Ajah, O., Nnaoma, I. E., & Joseph, R. C. (2026). ELUSINE CORACANA LEAF EXTRACT MITIGATES DYSLIPIDEMIA AND MODULATES INFLAMMATION BIOMARKERS IN TESTOSTERONE PROPIONATE - INDUCED BENIGN PROSTATIC HYPERPLASIA IN RATS. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v11i2.1535

Vancouver

Duru CA, Ajah O, Nnaoma IE, Joseph RC. ELUSINE CORACANA LEAF EXTRACT MITIGATES DYSLIPIDEMIA AND MODULATES INFLAMMATION BIOMARKERS IN TESTOSTERONE PROPIONATE - INDUCED BENIGN PROSTATIC HYPERPLASIA IN RATS. Universal Journal of Pharmaceutical Research. 2026. doi:10.22270/ujpr.v11i2.1535

BibTeX
@article{Duru2026,
  author = {Duru, Chioma Adaeze and Ajah, Obinna and Nnaoma, Ikenna Elvis and Joseph, Rich C},
  title = {ELUSINE CORACANA LEAF EXTRACT MITIGATES DYSLIPIDEMIA AND MODULATES INFLAMMATION BIOMARKERS IN TESTOSTERONE PROPIONATE - INDUCED BENIGN PROSTATIC HYPERPLASIA IN RATS},
  journal = {Universal Journal of Pharmaceutical Research},
  year = {2026},
  doi = {10.22270/ujpr.v11i2.1535}
}
Kostenlos starten →